Clinical Document Automation Solution
WinWire Technologies · Intelligence & Research
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 8 captures on record
What the publisher says
As described on Microsoft Marketplace.
Clinical research involves a lot of documentation, such as
study protocols, consent forms, study reports, and regulatory submissions.
Show the rest of the publisher’s description (55 more lines)
Healthcare and life sciences organizations find it challenging to manage all
this manually, especially when they have time constraints and productivity
demands. Therefore, it is crucial to have efficient solutions that can
streamline and automate the document management processes.
Regulatory compliance is essential in clinical research,
requiring accurate and compliant documentation to meet regulatory standards and
guidelines. As research projects become more complex and larger in scope,
scalable and adaptable solutions are necessary to manage the increasing volumes
of documents effectively.
WinWire’s
Clinical Document Automation Solution
WinWire’s Clinical Document Automation (WinCDA) Solution leverages
Generative AI and natural language generation (NLG) to revolutionize drug
development. By streamlining the creation and review of clinical trial
documents, our platform speeds up time-to-market for new drugs and
significantly reduces the risk of human error.
The solution generates
documents like informed consent forms and clinical
study reports that comply with regulatory standards set by the FDA, EMA,
and ICH, ensuring that users meet regulatory requirements. Additionally, WinCDA comes with features such as document
comparison for tracking changes and version control, which help to support
regulatory compliance.
Key Features
·
Enhanced Accuracy and Compliance
Assurance
Detects errors, inconsistencies, and deviations from
regulatory standards that human reviewers mistakenly overlook.
·
Faster Review Cycles and Time Savings
Document review times are significantly reduced. This
improved efficiency leads to shorter lead times for launching clinical trials
and bringing new drugs to market.
·
Improved Risk Mitigation and Patient
Safety
Identifies potential safety concerns or ethical issues
within clinical trial protocols. It can cross-reference historical data,
adverse event reports and best practices.
·
Faster Approvals
Minimize review cycles with automation that generates
formatted documents, reducing errors and the need for extensive edits.
Business
Value
- Clinical Study Report (CSR) – Reduces the
time required for CSR report writing, allowing for faster and more
efficient documentation processes.
- Clinical Trial Narrative – Effortlessly generate tables and
narratives for patient safety, enhancing accuracy and efficiency in
reporting.
- Protocol Summarization – Achieve comprehensive and
precise summaries effortlessly, saving time and ensuring consistency.
- Summary Clinical Safety – Automate the creation of module
summaries, ensuring consistent and precise safety data reporting.
Preview
1 imageAgent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-08-29
Sources
Publisher resources
3 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.

